Form 4: Elanco CEO Acquires Deferred Stock Units

Elanco Animal Health CEO Jeffrey N. Simmons acquired 154.6198 deferred stock units, increasing his beneficial ownership.

Summary

• Jeffrey N. Simmons, President, CEO, and Director of Elanco Animal Health Inc. (ELAN), acquired 154.6198 deferred stock units.
• The transaction occurred on August 22, 2025.
• Each deferred stock unit represents the right to receive one share of company common stock or its cash equivalent.
• These units settle in cash or shares upon termination of employment or during a specified future year, according to the Executive Deferral and Stock Match Plan.
• Following this transaction, Simmons beneficially owns 17,541.6535 deferred stock units.
• The price of the derivative security was $17.91 per unit.

Sentiment

Score: 7

Explanation: The acquisition of deferred stock units by the CEO is generally viewed positively as it aligns management's interests with long-term shareholder value. It's a routine compensation event, not a significant market-moving announcement, hence a moderately positive score.

Positives

• An insider, the CEO, acquired additional deferred stock units, which can be seen as a sign of confidence in the company's future performance.
• The acquisition aligns the CEO's long-term interests with those of shareholders through equity-based compensation.

Future Outlook

The acquisition of deferred stock units by the CEO implies a long-term commitment to the company's performance, as these units are tied to future settlement based on employment termination or a specified future year.

Industry Context

The use of deferred stock units as part of executive compensation is a common practice across various industries, including the animal health sector, to align executive interests with long-term shareholder value and retention.

Comparison to Industry Standards

• The utilization of deferred stock units for executive compensation is a standard practice observed in many publicly traded companies, including peers in the animal health industry such as Zoetis Inc. (ZTS) and IDEXX Laboratories (IDXX).
• This type of equity-based incentive plan is designed to align executive performance with long-term shareholder returns, a widely accepted corporate governance principle.
• The specific value and quantity of units granted would typically be benchmarked against compensation packages for executives in comparable roles and company sizes within the sector, though this filing does not provide sufficient detail for such a granular comparison.

Corporate Governance

Related Party Transactions

• The acquisition of deferred stock units by Jeffrey N. Simmons, the CEO and Director, is a transaction between an insider and the company, which is a form of related-party transaction, executed as part of an established executive compensation plan.

Stakeholder Impact

• Shareholders: The CEO's increased equity stake through deferred stock units can be viewed positively, as it aligns his long-term financial interests with those of the shareholders.
• Management/Employees: The transaction is part of an executive compensation plan, which can serve as an incentive for long-term performance and retention of key leadership.

Next Steps

• The deferred stock units will settle in cash or shares upon termination of employment or during a specified future year, in accordance with the Executive Deferral and Stock Match Plan.

Key Dates

Recommendation

The acquisition of deferred stock units by the CEO is a standard component of executive compensation, aligning management's long-term interests with the company's performance. While generally a positive signal of insider confidence, it is not an open-market purchase and does not provide new fundamental information to warrant a change in investment thesis. Therefore, a 'hold' recommendation is appropriate, maintaining existing positions while monitoring future company performance and broader market conditions.

Keywords

Elanco Animal Health, ELAN, Jeffrey N. Simmons, Deferred Stock Units, Insider Transaction, CEO, Executive Compensation, Stock Acquisition